Side effects of reflux medication
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of Reflux Medication: A Comprehensive Review
Introduction to Reflux Medication Side Effects
Gastroesophageal reflux disease (GERD) is a common condition that often requires pharmacological intervention. While these medications can be effective in managing symptoms, they are not without side effects. This article synthesizes findings from multiple studies to provide a comprehensive overview of the adverse effects associated with various reflux medications.
Proton Pump Inhibitors (PPIs) Side Effects
Common Adverse Effects of PPIs
Proton pump inhibitors (PPIs) such as omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole are widely used to treat GERD. However, they are associated with several side effects. Commonly reported adverse effects include headaches, diarrhea, nausea, and constipation. These side effects have been observed in approximately 34% of patients using PPIs1 4.
Long-term Risks
Long-term use of PPIs has been linked to more serious health concerns. These include an increased risk of lower respiratory tract infections and nosocomial sepsis, particularly in immune-deficient children or those with indwelling catheters1. Additionally, there are ongoing controversies regarding the potential for PPIs to cause kidney disease, bone fractures, and vitamin B12 deficiency4.
Histamine-2 Receptor Antagonists (H2RAs) Side Effects
Common Adverse Effects of H2RAs
Histamine-2 receptor antagonists (H2RAs) such as ranitidine, cimetidine, famotidine, and nizatidine are another class of medications used to treat GERD. Adverse effects are reported in at least 23% of patients and include headaches, diarrhea, and nausea1 4.
Controversies and Long-term Use
Similar to PPIs, the long-term use of H2RAs has been controversial. While these medications are generally considered safe, there are concerns about their potential to cause cognitive impairment in elderly patients and their association with an increased risk of infections due to acid suppression4.
Prokinetic Agents Side Effects
Metoclopramide and Domperidone
Prokinetic agents like metoclopramide and domperidone are used to enhance gastrointestinal motility. However, their use is often limited by their side effects. Metoclopramide is associated with neurological and psychotropic symptoms such as drowsiness, lethargy, hyperactivity, and even acute torticollis and depression3 5 7. Domperidone, while generally better tolerated, can cause galactorrhea and other side effects5.
Baclofen
Baclofen, a GABA agonist, has shown promise in treating GERD symptoms, particularly in PPI-resistant cases. However, it is not without side effects. Mild neurological and mental status deterioration have been reported, occurring in less than 5% of short-term users and nearly 20% of long-term users2.
Newer Medications and Their Side Effects
Vonoprazan Fumarate
Vonoprazan fumarate is a newer medication used to treat reflux esophagitis. It has been found to be effective with a relatively low incidence of adverse effects. Common side effects include dizziness, rash, and diarrhea, with an overall incidence of 3.92%, which is significantly lower than that of traditional PPIs8.
Lesogaberan
Lesogaberan, another novel treatment, has been shown to reduce the number of transient lower esophageal sphincter relaxations (TLESRs) and reflux episodes. The most common side effects reported are headaches and transient paresthesia9.
Conclusion
While reflux medications are effective in managing GERD symptoms, they come with a range of side effects that vary depending on the specific drug and duration of use. PPIs and H2RAs are associated with common gastrointestinal and neurological side effects, and their long-term use remains controversial. Prokinetic agents, although effective, often have significant neurological side effects. Newer medications like vonoprazan fumarate and lesogaberan show promise with fewer adverse effects, but further studies are needed to fully understand their safety profiles. Patients and healthcare providers must weigh the benefits and risks when choosing the appropriate treatment for GERD.
Sources and full results
Most relevant research papers on this topic
Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review
Adverse effects from pharmacological agents for paediatric GERD include headaches, diarrhoea, nausea, and constipation, with potential risks for immune-deficient infants and children with indwelling catheters.
Systematic Review
Highly CitedBaclofen as a therapeutic option for gastroesophageal reflux disease: A systematic review of clinical trials
Baclofen may improve gastroesophageal reflux disease symptoms and may be particularly beneficial for patients with concurrent conditions like alcohol use disorder, non-acid reflux, or obesity.
Systematic ReviewTreatment of severe reflux esophagitis with cimetidine and metoclopramide.
Cimetidine and metoclopramide effectively manage chronic reflux esophagitis, but should be reserved for patients refractory to cimetidine alone due to frequent side effects.
RCTHighly CitedSide effects of drug treatments for gastro-oesophageal reflux disease: current controversies
Proton pump inhibitors and histamine-2 receptor antagonists for gastro-oesophageal reflux disease treatment have been linked to a number of adverse effects, but their clinical significance is often based on associations rather than causal connections.
Literature ReviewDomperidone, metoclopramide, and placebo. All give symptomatic improvement in gastroesophageal reflux.
All three drugs (placebo, domperidone, and metoclopramide) significantly improve symptoms of gastroesophageal reflux, with no significant difference in improvement between them.
RCTReflux Symptoms and Side Effects Among Patients with Gastroesophageal Reflux Disease at Baseline, During Treatment with PPIs, and After Nissen Fundoplication
Reflux symptoms decreased after treatment with esomeprazole and were further reduced after Nissen fundoplication, with no increased treatment-related side effects.
Non-RCT
Rigorous JournalCimetidine, Metoclopramide, or Placebo in the Treatment of Symptomatic Gastroesophageal Reflux
Cimetidine or metoclopramide are more effective than placebo for relieving symptoms of gastroesophageal reflux disease, but metoclopramide has significant side effects.
RCTHighly CitedEffect of Medicine and Adverse Drug Reactions of Vonoprazan Fumarate Tablets in Patients with Reflux Esophagitis
Vonoprazan fumarate tablets effectively treat reflux esophagitis with low adverse reactions, making them a promising clinical treatment option.
RCTEffects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease.
Lesogaberan reduces reflux episodes and increases lower esophageal sphincter pressure in patients with gastroesophageal reflux disease despite proton pump inhibitor treatment.
RCTHighly CitedComparative effects of metoclopramide and bethanechol on lower esophageal sphincter pressure in reflux patients.
Metoclopramide 20 mg effectively increases lower esophageal sphincter pressure, potentially aiding in treating gastro-esophageal reflux.
RCTHighly Cited